ModerateVitamin K antagonist anticoagulants×Anilides. Analgesics and antipyretics
Updated · Methodology
Mechanism
Acenocoumarol is a vitamin K antagonist. The Spanish acenocoumarol SmPCs, both the originator and a generic, list paracetamol among drugs that can potentiate its anticoagulant effect (acenocoumarol summaries of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). According to the paracetamol SmPCs, chronic use of paracetamol at doses above 2 g a day may increase the effect of the oral anticoagulants acenocoumarol and warfarin. This may happen because the liver makes fewer clotting factors (paracetamol SmPC, AEMPS). At doses below 2 g a day the effect appears to be of little clinical relevance (paracetamol SmPC, AEMPS). The documents do not say how much the international normalised ratio (INR) rises.
Symptoms
The main risk is bleeding. Acenocoumarol can cause serious bleeding, including haemorrhagic shock, and fatal bleeding. The risk is higher with an international normalised ratio (INR) above 4.0, at age 65 or older and with concomitant treatment (acenocoumarol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). With excess acenocoumarol, the most frequent signs are bleeding into the skin and blood in the urine. Other signs include bruising, gastrointestinal bleeding, vomiting blood, uterine bleeding, nosebleeds, bleeding gums and bleeding into joints (acenocoumarol SmPC, AEMPS). Fast heartbeat, low blood pressure, nausea, vomiting, diarrhoea and abdominal pain may follow, and laboratory tests show a very high INR (AEMPS).
Management
The documents neither contraindicate nor prohibit this combination. In people taking anticoagulants, paracetamol is considered an alternative to salicylates (paracetamol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). When paracetamol is added to acenocoumarol or stopped, use close and frequent coagulation checks, for example twice a week (acenocoumarol SmPCs, AEMPS). The effect of acenocoumarol may increase with chronic use of paracetamol at doses above 2 g a day. At lower doses, the effect appears to be of little clinical relevance (paracetamol SmPC, AEMPS). This 2 g threshold is below the usual adult maximum of 4 g of paracetamol a day. People with chronic alcohol misuse should not take more than 2 g a day (paracetamol SmPC, AEMPS). With an international normalised ratio (INR) of 4.5–10 and no significant bleeding, interrupt acenocoumarol. In significant bleeding, interrupt it and give 5–10 mg of vitamin K1 intravenously very slowly, no faster than 1 mg per minute (acenocoumarol SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Paracetamol (nº registro 69478), sección 4.5 (2025)– AEMPS, CIMA, nº registro 69478, revisión 02/2025, sección 4.5
- AEMPS: Ficha técnica: Acenocumarol, Sintrom 4 mg (nº registro 25670), sección 4.5 (2025)– AEMPS, CIMA, nº registro 25670 (Sintrom 4 mg comprimidos, Merus Labs; texto de la sección 4.5 idéntico en Sintrom 1 mg, nº 58994), revisión 06/2025, sección 4.5
- AEMPS: Ficha técnica: Acenocumarol Aurovitas 4 mg (nº registro 88315), sección 4.5 (2025)– AEMPS, CIMA, nº registro 88315 (Acenocumarol Aurovitas 4 mg comprimidos EFG; texto idéntico en 1 mg, nº 88278), revisión 07/2025, sección 4.5
- AEMPS: Ficha técnica: Acenocumarol, Sintrom 4 mg (nº registro 25670), sección 4.9 (2025)– AEMPS, CIMA, nº registro 25670 (Sintrom 4 mg comprimidos, Merus Labs; texto de la sección 4.9 idéntico en Sintrom 1 mg, nº 58994), revisión 06/2025, sección 4.9
- AEMPS: Ficha técnica: Acenocumarol, Sintrom 4 mg (nº registro 25670), sección 4.4 (2025)– AEMPS, CIMA, nº registro 25670 (Sintrom 4 mg comprimidos, Merus Labs; texto de la sección 4.4 idéntico en Sintrom 1 mg, nº 58994), revisión 06/2025, sección 4.4
- AEMPS: Ficha técnica: Paracetamol, Paracetamol Stada 1 g (nº registro 69478), sección 4.2 (2025)– AEMPS, CIMA, nº registro 69478 (Paracetamol Stada 1 g comprimidos EFG), revisión 02/2025, sección 4.2